Sale!

NHP2 Gene Dyskeratosis Congenita Autosomal Recessive Type 2 Genetic Test

Original price was: $700.Current price is: $500.

-29%

The NHP2 Gene Dyskeratosis Congenita Autosomal Recessive Type 2 NGS Genetic DNA Test is a cutting-edge diagnostic tool that identifies mutations in the NHP2 gene responsible for this rare inherited disorder. Using next-generation sequencing technology, this comprehensive test provides definitive diagnosis for patients presenting with characteristic triad of abnormal skin pigmentation, nail dystrophy, and leukoplakia. The test is crucial for individuals experiencing bone marrow failure, premature aging symptoms, pulmonary complications, or family history of dyskeratosis congenita. Early detection enables proactive management and treatment planning. Results are delivered within 3-4 weeks from blood or DNA samples. This advanced genetic analysis is available for $500 USD, offering significant savings from the regular $700 price.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

NHP2 Gene Dyskeratosis Congenita Autosomal Recessive Type 2 NGS Genetic DNA Test

Comprehensive Genetic Analysis for Rare Inherited Disorder

The NHP2 Gene Dyskeratosis Congenita Autosomal Recessive Type 2 NGS Genetic DNA Test represents a breakthrough in molecular diagnostics for rare genetic conditions. This advanced testing methodology utilizes next-generation sequencing technology to provide definitive identification of mutations in the NHP2 gene, which plays a critical role in telomere maintenance and cellular aging processes.

What This Test Measures and Detects

This sophisticated genetic analysis specifically targets the NHP2 gene located on chromosome 5q35.3, which encodes the NHP2 ribonucleoprotein essential for telomerase RNA biogenesis. The test identifies:

  • Pathogenic variants in the NHP2 gene associated with dyskeratosis congenita
  • Autosomal recessive inheritance patterns
  • Specific mutations affecting telomere length maintenance
  • Genetic markers for bone marrow failure susceptibility
  • Risk factors for pulmonary fibrosis and liver complications

Who Should Consider This Genetic Test

This comprehensive genetic evaluation is recommended for individuals presenting with:

  • Classic triad of abnormal skin pigmentation, nail dystrophy, and oral leukoplakia
  • Unexplained bone marrow failure or aplastic anemia
  • Premature graying of hair or early aging symptoms
  • Family history of dyskeratosis congenita or related disorders
  • Recurrent pulmonary infections or pulmonary fibrosis
  • Liver abnormalities or gastrointestinal complications
  • Developmental delays or growth retardation in children
  • Increased cancer susceptibility, particularly squamous cell carcinoma

Clinical Benefits of NHP2 Genetic Testing

Early genetic diagnosis through NHP2 testing provides numerous clinical advantages:

  • Accurate Diagnosis: Differentiates dyskeratosis congenita from other bone marrow failure syndromes
  • Family Planning: Enables informed reproductive decisions and prenatal testing options
  • Proactive Management: Facilitates early intervention for bone marrow monitoring
  • Treatment Guidance: Informs appropriate therapeutic approaches including hematopoietic stem cell transplantation
  • Cancer Surveillance: Establishes baseline for regular cancer screening protocols
  • Genetic Counseling: Provides comprehensive risk assessment for family members

Understanding Your Test Results

Our comprehensive genetic counseling team will help interpret your NHP2 gene analysis results:

  • Positive Result: Indicates presence of pathogenic NHP2 mutations confirming dyskeratosis congenita diagnosis
  • Negative Result: Suggests absence of detectable NHP2 mutations, though other genetic causes may be considered
  • Variant of Uncertain Significance: Identifies genetic changes requiring further clinical correlation
  • Carrier Status: Determines if individuals carry one copy of mutated gene without disease manifestation

Test Pricing and Sample Requirements

Test Feature Details
Test Name NHP2 Gene Dyskeratosis Congenita Autosomal Recessive Type 2 NGS Genetic DNA Test
Discount Price $500 USD
Regular Price $700 USD
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card
Testing Method Next-Generation Sequencing (NGS) Technology

Nationwide Testing Availability

We provide comprehensive genetic testing services across the United States with convenient locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many other cities. Our state-of-the-art laboratories ensure consistent, reliable results regardless of your location.

Pre-Test Requirements and Genetic Counseling

Prior to testing, we recommend:

  • Comprehensive clinical history documentation
  • Genetic counseling session with our certified genetic counselors
  • Development of detailed family pedigree chart
  • Discussion of potential implications and limitations of testing
  • Informed consent process explaining benefits and risks

Take Control of Your Genetic Health Today

Don’t let uncertainty about genetic conditions affect your health decisions. Our NHP2 Gene Dyskeratosis Congenita test provides the clarity you need for informed medical management. With our discounted price of $500 USD (regularly $700), advanced genetic testing is more accessible than ever.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your genetic counseling session and book your NHP2 Gene Dyskeratosis Congenita Autosomal Recessive Type 2 NGS Genetic DNA Test. Our genetic specialists are ready to guide you through every step of the testing process and help you understand your results for better health outcomes.